Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy

Human Gene Therapy Clinical Development

Volumn 26, Issue 2, 2015, Pages 131-137

  Snyder, Jessica M ^a   Meisner, Allison ^a   Mack, David ^a   Goddard, Melissa ^a,b   Coulter, Ian T ^a   Grange, Robert ^c   Childers, Martin K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRONUCLEAR MYOPATHY; DISEASE SEVERITY; DOG; GENE; GENOTYPE; HISTOPATHOLOGY; MUSCLE BIOPSY; MYOTUBULARIN GENE; NEUROMUSCULAR ASSESSMENT SCORE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; VALIDITY; X CHROMOSOME LINKED DISORDER; X LINKED MYOTUBULAR MYOPATHY; ANIMAL; DISEASE MODEL; GAIT; GENE THERAPY; GENETICS; MUSCLE WEAKNESS; MYOPATHIES, STRUCTURAL, CONGENITAL; PATHOPHYSIOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

CANIS FAMILIARIS;

MYOTUBULARIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; GAIT; GENETIC THERAPY; MUSCLE WEAKNESS; MYOPATHIES, STRUCTURAL, CONGENITAL; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 85006215439     PISSN: 23248637     EISSN: 23248645     Source Type: Journal    
DOI: 10.1089/humc.2015.049     Document Type: Article

References (24)

1. Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 1996;13:175-182.
2. Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008;3:26.
3. Taratuto AL. Congenital myopathies and related disorders. Curr Opin Neurol 2002;15:553-561.
4. Biancalana V, Caron O, Gallati S, et al. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet 2003;112:135-142.
5. Das S, Dowling J, Pierson CR. X-linked centronuclear myopathy. In: GeneReviewsO® (Internet). RA Pagon, MP Adam, TD Bird, et al., eds. (Seattle, WA) University of Washington, Seattle;1993-2015.
6. Pierson CR, Tomczak K, Agrawal P, et al. X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol 2005;64:555-564.
7. Joseph M, Pai GS, Holden KR, et al. X-linked myotubular myopathy: clinical observations in ten additional cases. Am J Med Genet 1995;59:168-173.
8. Cosford KL, Taylor SM, Thompson L, et al. A possible new inherited myopathy in a young Labrador retriever. Can Vet J 2008;49:393-397.
9. Beggs AH, Bohm J, Snead E, et al. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci USA 2010;107:14697-14702.
10. Snead EC, Taylor SM, van der Kooij M, et al. Clinical phenotype of X-linked myotubular myopathy in labrador retriever puppies. J Vet Intern Med 2015;29:254-260.
11. Goddard MA, Mitchell EL, Smith BK, et al. Establishing clinical end points of respiratory function in large animals for clinical translation. Phys Med Rehabil Clin N Am 2012;23:75-94, xi.
12. Childers MK, Joubert R, Poulard K, et al. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Sci Transl Med 2014;6:220ra210.
13. McCurdy VJ, Rockwell HE, Arthur JR, et al. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. Gene Ther 2015;22:181-189.
14. McCurdy VJ, Johnson AK, Gray-Edwards HL, et al. Sustained normalization of neurological disease after intracranial gene therapy in a feline model. Sci Transl Med 2014;6:231ra248.
15. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-579.
16. Brown A, Woods S, Skinner R, et al. Neurological assessment scores in rabbit embolic stroke models. Open Neurol J 2013;7:38-43.
17. Zu QQ, Liu S, Xu XQ, et al. An endovascular canine stroke model: middle cerebral artery occlusion with autologous clots followed by ipsilateral internal carotid artery blockade. Lab Invest 2013;93:760-767.
18. Purdy PD, Devous MD Sr., Batjer HH, et al. Microfibrillar collagen model of canine cerebral infarction. Stroke 1989;20:1361-1367.
19. Goddard MA, Burlingame E, Beggs AH, et al. Gait characteristics in a canine model of X-linked myotubular myopathy. J Neurol Sci 2014;346:221-226.
20. Tegeler CJ, Grange RW, Bogan DJ, et al. Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs. Muscle Nerve 2010;42:130-132.
21. Grange RW, Doering J, Mitchell E, et al. Muscle function in a canine model of X-linked myotubular myopathy. Muscle Nerve 2012;46:588-591.
22. Childers MK, Grange RW, Kornegay JN. In vivo canine muscle function assay. J Vis Exp 2011; (50). pii: 2623.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
24. Bland JM, Altman DG. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med 1990;20:337-340.